__NUXT_JSONP__("/drugs/Src_Kinase_Inhibitor_M475271", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"476159-98-5",chebiId:b,chemicalFormula:b,definition:"An inhibitor of Src tyrosine kinase, with potential antineoplastic activity. Upon administration, Src kinase inhibitor M-475271 targets and binds to Src kinase. This inhibits Src-mediated signaling and the proliferation of tumor cells overexpressing Src. Src tyrosine kinase, a non-receptor tyrosine kinase upregulated in many tumor cell types, plays an important role in tumor cell proliferation, motility, invasiveness and survival.",fdaUniiCode:"0361Z8214O",identifier:"C162339",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C1967"],synonyms:["4-Quinazolinamine, N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-","AZM 475271","AZM-475271","AZM475271","M 475271","M-475271","M475271","N-(2-Chloro-5-methoxyphenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FSrc_Kinase_Inhibitor_M475271",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Src_Kinase_Inhibitor_M475271","","Src Kinase Inhibitor M475271","2021-10-30T13:35:17.953Z")));